About Neuronex
Neuronex is a company based in Morrisville (United States) founded in 2010 was acquired by Acorda in February 2012. Neuronex has raised $1.5 million across 2 funding rounds from investors including Acorda. Neuronex operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Morrisville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuronex, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neuronex
Neuronex has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $400 thousand completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neuronex
Neuronex has secured backing from 1 investor. Prominent investors backing the company include Acorda.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Engaged in the development and commercialization of therapies that improve neurological function.
|
Locked | Locked | Locked |
Investor details for Neuronex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuronex
Investment portfolio details for Neuronex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuronex
Detailed financials for Neuronex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuronex Comparisons
Peer comparison for Neuronex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuronex
Neuronex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Therapies for neurological and neuropsychiatric diseases are developed.
|
Detailed competitors of Neuronex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuronex
Complete news archive for Neuronex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuronex
Neuronex was founded in 2010.
Neuronex is headquartered in Morrisville, United States.
Neuronex is a funded company, having raised a total of $1.5M across 2 funding rounds to date.
Neuronex was founded in 2010 in Morrisville, United States, as a development-stage company targeting Central Nervous System diseases. A proprietary nasal spray version of diazepam, licensed from SK Biopharmaceuticals, is being developed as rescue medication for patients with seizure disorders. The company was acquired by Acorda in 2012, shifting its operations under the new ownership.
Neuronex's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.
Neuronex has 1 investor. Key investors include Acorda.